Avalyn Pharma (AVLN)

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

O preço da ação Avalyn Pharma Inc. Common Stock (AVLN) hoje é de $ 28,21, refletindo uma movimentação de +5,20% desde que o mercado abriu. A capitalização de mercado da empresa é de $ 1,18 bi, com um volume comercial diário de $ 42,07 mil ações. Para investidores monitorando tendências de preços, a ação Avalyn Pharma Inc. Common Stock tem variado entre $ 26,69 e $ 28,95 hoje. O preço de fechamento anterior foi $ 26,82.

Vamos começar? Siga os passos abaixo ou leia nosso guia sobre como comprar Avalyn Pharma ações na Kraken a partir de US$ 10.